TP53 and cancer: Akin to MDM2-mediated negative regulation of p53, E6-UBE3A disables the tumor-suppressive functions of p53, leading to unrestricted proliferation, impaired apoptosis and genomic instability toward the development of HPV-associated cancers [143].